O’Heeron Peter's most recent trade in FibroBiologics Inc was a trade of 406,339 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 27, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
FibroBiologics Inc | O’Heeron Peter | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 406,339 | 406,339 | - | - | Stock Option (Right to Buy) | |
FibroBiologics Inc | Peter O’Heeron | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Dec 2024 | 100,000 | 5,906,647 | - | 0 | Common Stock | |
FibroBiologics Inc | Peter O’Heeron | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Dec 2024 | 50,000 | 6,006,647 | - | 0 | Common Stock | |
FibroBiologics Inc | Peter O’Heeron | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 12 Aug 2024 | 8,500 | 6,056,647 | - | 1.9 | 16,269 | Common Stock |